INSULIN-DEPENDENT DIABETES
A Public Health Challenge
MSF is seeing a steady increase in diabetes consultations across its projects. Yet, major inequalities persist: in low- and middle-income countries (LMICs), a 10-year-old child with type 1 diabetes (T1D) has an average life expectancy of just 13 years, compared to 65 years in high-income countries. The high cost of insulin and blood glucose monitoring devices severely limits access to care, forcing some patients to travel long distances multiple times a day for treatment—often at the risk of their safety.
In these settings, insulin and monitoring tools are often not covered by public health systems, and clinicians do not always receive the necessary training to manage this complex disease.
MSF’s Commitment
In response to these challenges, MSF is developing a care model that promotes patient autonomy through several key initiatives:
- Medical training and patient education
In partnership with the NGO Santé Diabète, MSF is developing educational tools to improve healthcare workers’ training and raise patient awareness about managing their condition.
- Improving access to treatment
MSF is introducing widely used devices from high-income countries, such as insulin pens and glucometers that allow at-home monitoring.
These initiatives are currently being tested in the field, particularly in Carnot (Central African Republic) and Aweil (South Sudan), where virtual and in-person training sessions have already significantly improved clinicians' knowledge of insulin-dependent diabetes. However, managing this disease remains particularly challenging in unstable contexts, where poverty and food insecurity exacerbate the difficulties.
The Role of MSF Foundation: Innovating for Adapted Solutions
To go further, the MSF Foundation is exploring new approaches to make diabetes care more accessible and better suited to field realities. With its expertise in managing innovative projects and bringing together diverse stakeholders, the Foundation plays a key role in identifying and developing groundbreaking solutions.
One area of focus is the shortage of specialized clinicians. The Foundation is exploring the potential of a clinical decision-support tool that could analyze glucometer readings and provide therapeutic recommendations, helping healthcare workers adjust treatments effectively. This hypothesis now requires validation.
Currently, the MSF Foundation is conducting in-depth research to:
- Identify challenges in diabetes management across different operational contexts.
- Assess existing solutions and their adaptability to MSF environments.
- Determine the conditions for developing or partnering on a concrete project.
If this initiative moves forward, a structured project will be launched with MSF teams' engagement, Board support, an allocated budget, a dedicated team, identified partners, and a steering committee composed of specialists and MSF members to ensure rigorous oversight.